Diabetogenic action of statins — mechanisms and consequences. Review

Autor: V. O. Serhiyenko, O. O. Serhiyenko

Publikováno v: Clinical Endocrinology and Endocrine Surgery; No. 2 (2022); 69-80
Clinical Endocrinology and Endocrine Surgery; № 2 (2022); 69-80

Over the past 20 years, the data according to the primary and secondary prevention of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (DM 2), usually using predefined subgroup analyses, has consistently shown conclusive evidenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71d30c4db38afc008398f7307205c70
https://doi.org/10.30978/cees-2022-2-69